Clinical Trial Update: Frequent Hemodialysis Network: Nocturnal Trial [Phase 2, Phase 3]

View source ↗

Summary

An update on the Frequent Hemodialysis Network: Nocturnal Trial (Phase 2/Phase 3) sponsored by NIDDK, involving patients with end-stage renal disease on hemodia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: End Stage Renal Disease, Hemodialysis | Phase 2, Phase 3 | Status: UNKNOWN